GSK, UNC-Chapel Hill partner to accelerate search for HIV cure
The University of North Carolina at Chapel Hill and GlaxoSmithKline (GSK) are creating a new HIV research center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS.